The Lovesac Company Introduces Cush Seating Platform
The Lovesac Company has launched Cush, a new modular seating platform designed to provide a spacious, deep-cushioned lounging experience.
Stocks · News reference
Cannara Biotech Inc. has scheduled the release of its financial results for the fiscal fourth quarter and fiscal year ended August 31, 2026, for November 30, 2026.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
The Lovesac Company has launched Cush, a new modular seating platform designed to provide a spacious, deep-cushioned lounging experience.
The Lovesac Company announced its participation in the 2026 Global Consumer & Retail Conference hosted by Telsey Advisory Group on October 8, 2026. The company will participate in a fireside chat that will be webcast live on its investor relations website.
Lovesac beat Q2 EPS estimates but missed sales; raised FY27 EPS guidance, cut revenue outlook, and analysts lowered price targets.
DA Davidson analyst Michael Baker maintains Lovesac (NASDAQ:LOVE) with a Buy and lowers the price target from $20 to $18.
Analysts raised targets for Darden, ServiceNow, Robinhood, Ibex and Workiva, while cutting targets for McDonald’s, Cerenome and Wingstop.
Canaccord Genuity analyst Maria Ripps maintains Lovesac (NASDAQ:LOVE) with a Buy and lowers the price target from $22 to $20.